Elevated visfatin levels in obese children are related to proinflammatory factors

Rui-Zhen Li1, Xi n-Yu Ma, Xiu-Fen Hu

  • 1Department of Endocrinology, Huazhong University of Science and Technology, Wuhan, China.

Insights

Obese children show higher visfatin and inflammatory markers, but visfatin

Area of Science:

  • Endocrinology and Metabolism
  • Pediatric Obesity Research
  • Inflammation Biology

Background:

  • Obesity is linked to chronic low-grade inflammation, involving abnormal cytokine production.
  • Visfatin is identified as both an adipokine and an inflammatory cytokine.
  • Understanding visfatin's role in pediatric obesity and inflammation is crucial.

Purpose of the Study:

  • To investigate the association between serum visfatin levels and systemic inflammation markers (hs-CRP, IL-6, TNF-a) in Chinese obese children.
  • To assess the relationship between visfatin concentrations and insulin resistance in this population.
  • To explore potential gender differences in these associations.

Main Methods:

  • Study included 44 obese and 50 normal-weight Chinese children.
  • Measurements included anthropometrics, blood pressure, and fasting levels of visfatin, hs-CRP, IL-6, TNF-a, glucose, insulin, and lipids.
  • Insulin resistance was assessed using the homeostasis model assessment (HOMA-IR).

Main Results:

  • Obese children had significantly higher serum visfatin, hs-CRP, and IL-6 levels compared to controls.
  • No significant difference in TNF-a levels or between genders for these markers.
  • Visfatin correlated with BMI and IL-6 in boys only, not with insulin resistance.

Conclusions:

  • Circulating visfatin's association with anthropometric and inflammatory factors is gender-dependent.
  • No correlation was found between serum visfatin and insulin resistance in this cohort.
  • Visfatin may serve as a key inflammatory cytokine indicating a low-grade inflammatory state in obesity.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...